Monitoring COVID-19 disease: the contribution of biological markers

Mandy Campbell from HORIBA Medical provides an overview of COVID-19 screening, prognosis and severity assessment, with a particular focus on the role of biomarkers and the value of point-of-care testing in the initial triage of patients.

This story is Premium Content and is only available to registered users. Please log in to view the full text. If you don't already have an account, please register with us completely free of charge.